SS
EW icon

SBI Securities’s Edwards Lifesciences EW Stock Holding History

SBI Securities’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$51K Sell
564
-32
-5% -$2.68K ﹤0.01% 1150
2026
Q1 		$47.7K Buy
596
+49
+9% +$4.04K ﹤0.01% 1115
2025
Q4 		$46.6K Sell
547
-222
-29% -$18.2K ﹤0.01% 1112
2025
Q3 		$59.8K Sell
769
-28
-4% -$2.19K ﹤0.01% 1019
2025
Q2 		$62.3K Sell
797
-52
-6% -$3.88K ﹤0.01% 973
2025
Q1 		$61.5K Buy
849
+11
+1% +$787 ﹤0.01% 907
2024
Q4 		$62K Buy
+838
New +$58.7K ﹤0.01% 909

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

SBI Securities's EW Position: Q2 2026 in Review

SBI Securities reduced its Edwards Lifesciences (EW) stake by 5.4% in Q2 2026, selling an estimated $2.68K and leaving 564 shares worth $51K. The position accounts for ﹤0.01% of the portfolio, ranked #1150.

SBI Securities first reported a position in EW in Q4 2024 and has held it in 7 quarters since. The position peaked at $62.3K in Q2 2025. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • SBI Securities held 564 shares of Edwards Lifesciences worth $51K as of Q2 2026.
  • SBI Securities sold 32 Edwards Lifesciences shares in Q2 2026, an estimated $2.68K.
  • Edwards Lifesciences made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #1150 holding.
  • SBI Securities first reported a position in Edwards Lifesciences in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Edwards Lifesciences position peaked at $62.3K in Q2 2025.
  • 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.